For moderate to severe rheumatoid arthritis (RA) in adult TNFi-IR patients1
For active psoriatic arthritis (PsA) in adult TNFi-IR patients1
For active ankylosing spondylitis (AS) in adult TNFi-IR patients1
Expectations
Challenge treatment goals
in RA, PSA, AND AS1
Visit the U.S. site to learn
about the efficacy and
safety
of RINVOQ in rheumatology
IR=intolerance or inadequate response; TNFi=tumor necrosis factor inhibitor
ONE EXCEPTIONAL PATIENT EXPERIENCE
Care
Specialists*
Empower patients
Our Care Specialists are the heart of AbbVie Contigo
Care Specialists provide 1:1 support to help patients start and stay on track with their prescribed treatment plan, including:
- Help patients understand the importance of following the treatment plan prescribed by their healthcare professional.
- Committed to answering questions throughout the experience to help limit treatment disruptions.
- Answer patients’ insurance questions and connect them with additional insurance expertise.
- Identify ways for patients to save on prescription costs.
Access
Specialists
Insurance support when needed
- Resource with expertise on Medicare and commercial plans at a national, local, and program level so that they can educate on potential options to consider based on each patient's unique financial situation.
- Can educate on payer prior authorization and appeal processes so you can determine the best access option for each patient's unique situation.
Access & Savings
Help with access &
treatment affordability
AbbVie Contigo can help your commercial patients save:
- With the Ahorros Contigo Savings Card, your eligible commercially insured patients may pay as little as $5 per prescription.†
- AbbVie Contigo may help eligible commercially insured patients experiencing initial coverage delays or denials access their prescribed therapy at no charge while coverage is established.‡
To enroll a patient in AbbVie Contigo:
1
Fill out the form with your patient
This form enrolls your patient and can be used to initiate a prescription with your patient's preferred speciality pharmacy.
2
Fill out the patient support prescription on Section 8
This may help your commercially insured patients get access to RINVOQ if they experience a delay or denial in their insurance coverage.‡
3
Fax the form to 1-678-727-0690 and to the patient's chosen specialty pharmacy
You will receive a call from an Access Specialist to discuss next steps. In addition, fax the form to your patient’s specialty pharmacy if using the Pharmacy Prescription in Section 6.
Fax the form to 1-678-727-0690 and to the patient's chosen specialty pharmacy
You will receive a call from an Access Specialist to discuss next steps. In addition, fax the form to your patient’s specialty pharmacy if using the Pharmacy Prescription in
Section 6.
4
Inform your patient that they have been enrolled
Let your patient know that they will be receiving a call from their Care Specialist.*
Get started with the Enrollment & Prescription Form
*Care Specialists are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing health care professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals.
†Terms and Conditions apply. This benefit covers RINVOQ® (upadacitinib). Eligibility: Available to patients with commercial prescription insurance coverage for RINVOQ who meet eligibility criteria. Co‑pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government‑funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government‑funded healthcare program, patient will no longer be able to use the Ahorros Contigo Savings Card for RINVOQ and patient must call AbbVie Contigo at 1.855.CONTIGO to stop participation. Patients moving or residing outside Puerto Rico may not be eligible. Patients may not seek reimbursement for value received from the AbbVie Contigo program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This assistance offer is not health insurance. To learn about AbbVie’s privacy practices and your privacy choices, visit www.abbvie.com/privacy.html.
‡Eligibility criteria: Available to patients aged 63 or younger with commercial insurance coverage. Patients must have a valid prescription for RINVOQⓇ (upadacitinib) for an FDA approved indication and a denial of insurance coverage based on a prior authorization request on file along with a confirmation of appeal. Continued eligibility for the program requires the submission of an appeal of the coverage denial every 180 days. Program provides for RINVOQ at no charge to patients for up to two years or until they receive insurance coverage approval, whichever occurs earlier, and is not contingent on purchase requirements of any kind. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Offer subject to change or discontinuance without notice. This is not health insurance and program does not guarantee insurance coverage. No claims for payment may be submitted to any third party for product dispensed by program. Limitations
may apply.